The Angeles Clinic and Research Institute | May 22, 2025
15th Annual Los Angeles Melanoma Symposium with the Angeles Clinic and Research Institute
Join us for the 15th Annual Los Angeles Melanoma Symposium, presented in partnership with The Angeles Clinic and Research Institute, a Cedars-Sinai Affiliate. This informative and empowering event is designed for patients, survivors, caregivers, and advocates to explore the latest advancements in melanoma treatment. With a focus on cutting-edge therapies, clinical trials, and emerging research, the symposium offers a unique opportunity to hear directly from leading melanoma experts and engage in meaningful Q&A. Don’t miss this chance to gain valuable insights and connect with a community dedicated to improving melanoma outcomes.
Date: Thursday – May 22, 2025
Time: 7:00 PM (EST) | 6:00 PM (CST) | 5:00 PM (MST) | 4:00 PM (PST)
(double-check your local time with this time zone converter)
Format: Presented virtually (REGISTER below)
Presenters & Topics
4:00 PM (PT)
Welcome and Introductions
Lawrence D. Piro, MD
President and CEO of The Angeles Clinic and Research Institute
4:10 PM (PT)
Intelligent Immunotherapy Innovations in Initial & Second Line Therapy
Justin T. Moyers, MD
Phase I & Experimental Program
The Angeles Clinic and Research Institute
4:40 PM (PT)
Breakthroughs in Care of Ocular Melanoma
Inderjit Mehmi, MD
Medical Oncology
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate
5:00 PM (PT)
Neoadjuvant and Adjuvant Therapy: Questions Getting Answered
Omid Hamid, MD
Co-Director, Melanoma Research Program
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate
5:20 PM (PT)
Clinical Trial Options, New Data, Future Therapies
Inderjit Mehmi, MD
Medical Oncology
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate
5:40 PM (PT)
TIL Tomorrow and Further
Mark B. Faries, MD
Co-Director, Melanoma Research Program
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate
6:00 PM (PT)
Q&A with Presenters & Closing Remarks with Sam Guild, President, AIM at Melanoma